This facility helps UC San Diego and external investigators transition cell therapies through IND-enabling and Phase I/II clinical studies. The ACTL features the following capabilities:
- Optimizing manufacturing processes, including scale-up, closed systems, and delivery formats
- Development of Standard Operating Procedures and Batch Production Records
- Cell product manufacturing, including cell enrichment with the CliniMACS System
- Cell product characterization, including standard microbiological release assays, flow cytometry and RT-qPCR assessment
- Secure storage of cell banks and cell products
- Materials risk assessment and selection
- Writing or review of CMC or supporting reports
Services Request
Download Proposal Form